Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2025-12-26 @ 3:48 AM
Study NCT ID:
NCT01077518
Status:
TERMINATED
Last Update Posted:
2020-03-27
First Post:
2010-02-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08-26
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-26
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-25
First Submit QC Date:
None
Study First Post Date:
2010-03-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-24
Results First Submit QC Date:
None
Results First Post Date:
2020-03-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-02-15
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-03-25
Last Update Post Date:
2020-03-27
Last Update Post Date Type:
ACTUAL